In patients with NSCLC, SRXN1 and KRT6A expression was associated with the tumor–node–metastasis (TNM) stage, presence of metastasis, history of smoking and daily smoking consumption. The gene discussed is KRT6A; the disease is non-small cell lung carcinoma.